Navigation Links
Cardium Announces Temporary Adjournment of Annual Meeting To Be Reconvened On July 2, 2013
Date:6/21/2013

in subsequent studies or in actual use; that new clinical studies will be successful or will lead to approvals or clearances from health regulatory authorities, or that approvals in one jurisdiction will help to support studies or approvals elsewhere; that certain elements of the preferred stock financing or other matters submitted for approval by stockholders will be approved by stockholders; that the Company will satisfy the requirements of its compliance plan and will otherwise continue to satisfy the listing requirements of its exchange or that its shares can continue to be listed on a national exchange; that we can raise sufficient capital from partnering, monetization or other fundraising transactions to maintain our stock exchange listing or adequately fund ongoing operations; that the Company can attract suitable commercialization partners for our products or that we or partners can successfully commercialize them; that our product or product candidates will not be unfavorably compared to competitive products that may be regarded as safer, more effective, easier to use or less expensive or blocked by third party proprietary rights or other means; that the products and product candidates referred to in this report or in our other reports will be successfully commercialized and their use reimbursed, or will enhance our market value; that our To Go Brands business can be successfully integrated and expanded; that new product opportunities or commercialization efforts will be successfully established; that third parties on whom we depend will perform as anticipated; that the preferred stock offering can be completed as proposed or that the Company will not be adversely affected by risks and uncertainties that could impact our operations, business or other matters, as described in more detail in our filings with the Securities and Exchange Commission. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements t
'/>"/>
SOURCE Cardium Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Cardium Reports On NYSE MKT Noncompliance Notice And Compliance Plan
2. Cardium Announces Patent Award For Rights To Cardiovascular Gene Therapy For The Treatment Of Heart Disease
3. Published Findings In Human Gene Therapy Methods Journal Demonstrate Cardiums New Catheter-Based Method Significantly Boosts Gene Delivery To The Heart
4. Cardium Presents First Quarter 2012 Financial Results and Recent Developments
5. Cardium to Present at Upcoming Investor Conferences
6. China Green Agriculture Inc. Announces Ministry of Agriculture Engaged Gufeng as Corporate Participant in the Ministrys Fertilizer Promotion Program
7. Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System
8. Techne Corporation Announces Acquisition Agreement
9. NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI
10. Acne and Rosacea Awareness Month: Probiotic Action Announces their Daily News Updates with Insight on the Most Common Skin Conditions
11. Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... The 20 ambassadors representing the ALS Therapy ... the following statement on Facebook today regarding the global ... funding specifically for ALS research: , “Who would have ... would raise all this awareness and funding toward ALS ... behalf of the entire ALS community, would like to ...
(Date:8/26/2014)... LONDON , Aug. 26, 2014 An ... gene structures of all Dengue virus strains in Pubmed, ... structures back to 1944. This conservation and sharing of ... a Synthetic Dengue Blocker-Vaccine™ candidate, as it did for ... vaccine, both of which have been found to be ...
(Date:8/26/2014)... 2014 The global market for molecular ... 2020, according to a new study by Grand View ... and the subsequent introduction of advanced cancer diagnostic technologies ... over the next six years. Moreover, the growing global ... cancer, coupled with disease triggering lifestyle habits such as ...
(Date:8/26/2014)... , Aug. 26, 2014   Loveland Products, a ... of high-performance crop input products and proprietary products ... the company has acquired a controlling interest in ... biotechnology company delivering biochemical-based products for efficient and ... Products, fastest growing plant nutrition brands, Accomplish ® ...
Breaking Biology Technology:ALS TDI’s Young Faces of ALS Ambassadors Thank You for Accepting the Ice Bucket Challenge to End ALS 2ALS TDI’s Young Faces of ALS Ambassadors Thank You for Accepting the Ice Bucket Challenge to End ALS 3ALS TDI’s Young Faces of ALS Ambassadors Thank You for Accepting the Ice Bucket Challenge to End ALS 4World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 2World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 3World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 4World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 5World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 6Agrium, through Loveland Products, Acquires a Controlling Interest in Agricultural Biotechnology Company Agricen 2Agrium, through Loveland Products, Acquires a Controlling Interest in Agricultural Biotechnology Company Agricen 3Agrium, through Loveland Products, Acquires a Controlling Interest in Agricultural Biotechnology Company Agricen 4
... NEW YORK, April 7 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals,Inc. ("Biostar" or the "Company") ... December 31, 2008. , , Highlights for Year Ended ... year were $33.9 million, up from $15.9 million, ... year increased 69% to $6,690,542 as compared to, ...
... ( http://www.volersystems.com ) has launched a "Quality System for ... concept and design to production of devices for human ... from investing in key programs that are critical to ... medical devices. During the economic recovery to come, Voler ...
... CARMEL, Israel, April 7 InSightec Ltd. announced,today that ... label,change for the company,s ExAblate(R) 2000 MR-guided Focused Ultrasound,(MRgFUS) ... fibroids. Under the new labeling, the agency allows,physicians to ... its previous,restriction to only treat up to half the ...
Cached Biology Technology:Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008 2Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008 3Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008 4Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008 5Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008 6Voler Systems Continues Investments and Expands Services 2FDA Approves Label Change for Non-Invasive Fibroid Treatment 2FDA Approves Label Change for Non-Invasive Fibroid Treatment 3
(Date:8/27/2014)... New York, NY (June, 2014) Outstanding basic ... treatments, and a dedication to patient care have ... of Columbia University Medical Center (CUMC) and NewYork-Presbyterian ... Grant from the National Cancer Institute (NCI). The ... only two NCI-designated Comprehensive Cancer Centers in New ...
(Date:8/27/2014)... that piglets can be weaned later with no negative ... the study at the University,s Roseworthy campus, published in ... important finding for pig producers. It allows improvements in ... "Sows don,t usually start their oestrous cycles again during ... been weaned," says Ms Alice Weaver, PhD candidate with ...
(Date:8/26/2014)... Researchers at Washington University in St. Louis have developed ... bones prone to tearing or breaking. The technology, which ... patients, one day may help pinpoint minor strains and ... problems occur. , The research is available online Aug. ... Interface , which publishes research at the nexus of ...
Breaking Biology News(10 mins):Herbert Irving Comprehensive Cancer Center awarded $18 million grant 2Herbert Irving Comprehensive Cancer Center awarded $18 million grant 3Herbert Irving Comprehensive Cancer Center awarded $18 million grant 4Piglet weaning age no bar to litter frequency 2New technology may identify tiny strains in body tissues before injuries occur 2New technology may identify tiny strains in body tissues before injuries occur 3
... at the edge of Alaska,s tundra are growing faster, suggesting ... rapidly warming climate, says a new study. While forests ... attributed to global warming, some white spruce trees in the ... last hundred years, especially since 1950, the study has found. ...
... bike path in Montana to a backwater underneath a ... June to capture high-resolution images for the first Nearby ... in their efforts to document global biodiversity as they ... week of Dec. 19-26., The GigaBlitz is organized ...
... University of Sheffield comparing rats and mice with their ... an important milestone in the evolution of mammals from ... tracking, the research team, which was led by Professor ... shed light on how rodents such as mice and ...
Cached Biology News:Trees on tundra's border are growing faster in a hotter climate 2Trees on tundra's border are growing faster in a hotter climate 3Trees on tundra's border are growing faster in a hotter climate 4GigaBlitz event seeks citizen scientists to capture images of nearby biodiversity 2GigaBlitz event seeks citizen scientists to capture images of nearby biodiversity 3Whiskers marked milestone in evolution of mammals from reptiles 2
... pH 9 (x 10) This product ... for heat-induced target retrieval prior to immunohistochemical ... on formalin-fixed, paraffin-embedded tissue sections mounted on ... buffer, pH 6, the use of Target ...
... to off-white solid. Increases the expression of glutathione ... in H 2 O. Unstable in aqueous ... EK7713840, CAS 3211-76-5, M.W. 196.1. References: ... and Junod, A.F. 1995. Biochem. J. ...
... antifade reagent is used to ... standard fluorescence microscopy. The unique ... a wide variety of fixed ... fluorescein, rhodamine, sulforhodamine 101, coumarin, ...
...
Biology Products: